“ Biotron has generated a compelling package of preclinical and clinical data supported by a robust patent portfolio. The anticipated data from the two Phase 2 HIV-1 clinical trials plus the Phase 2 COVID-19 clinical trial in the second half of 2023 is expected,if positive, to trigger substantive engagement with potential partners. Groundwork has been laid during previous discussions during the development process.”
“ Biotron has generated a compelling package of preclinical and...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.004(7.14%) |
Mkt cap ! $54.13M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 6.3¢ | 5.7¢ | $92.07K | 1.570M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16017 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 104736 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.0¢ |
Change
0.004 ( 7.14 %) |
||||
| Open | High | Low | Volume | ||
| 5.6¢ | 6.3¢ | 5.6¢ | 239420 | ||
| Last updated 15.55pm 07/05/2024 ? | |||||
| BIT (ASX) Chart |